Related Experiment Video
Updated: Jan 9, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Engineered Multilamellar Cationic Liposomes with High Loading Efficiency and Stability for Enhanced Transdermal
Wanping Zhang1,2, Zhe Li2, Xun Bu2
1Collaborative Innovation Center of Fragrance Flavour and Cosmetics, School of Perfume and aromtechnology, Shanghai Institute of Technology, Shanghai 201418, China.
Multilamellar cationic liposomes (MCLs) offer a stable, non-irritating transdermal drug delivery solution. These novel liposomes demonstrate enhanced permeation and high encapsulation efficiency for therapeutics like retinol.
Area of Science:
- Materials Science
- Biotechnology
- Pharmaceutics
Background:
- Cationic liposomes (CLs) are promising drug carriers due to biodegradability and permeation.
- Challenges with CLs include irritation, stability, and effective transdermal delivery.
Purpose of the Study:
- To develop stable, non-irritating multilamellar cationic liposomes (MCLs) for enhanced transdermal delivery.
- To investigate the molecular assembly and characterize the properties of the developed MCLs.
Main Methods:
- MCLs were formulated using soy lecithin, cholesterol, and a cationic surfactant in a polyol solvent.
- Molecular assembly was studied using isothermal titration calorimetry (ITC) and 2D-ROESY.
- Safety and efficacy were assessed via chick chorioallantoic membrane assays and porcine ear skin permeation studies.
Main Results:
- MCLs exhibited an onion-like structure, ~300 nm size, and high zeta potentials (40-60 mV).
- Chick chorioallantoic membrane assays showed minimal bleeding (ESI < 12), indicating non-irritancy.
- Retinol-loaded MCLs achieved 80.29% encapsulation and demonstrated significantly higher cumulative release in porcine skin.
Conclusions:
- The developed MCLs provide a stable and efficient platform for transdermal drug delivery.
- This formulation overcomes key limitations of traditional CLs, offering improved safety and efficacy.
- MCLs represent a strategic advancement for next-generation transdermal systems.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement

